An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor

SZ Zhu, SZ Wang, J Hu and EE el-Fakahany

Division of Neuroscience Research in Psychiatry, University of Minnesota Medical School, Minneapolis 55455.

An exceptionally conserved sequence that is shared among most G protein- coupled neurotransmitter receptors is an aspartate-arginine-tyrosine triplet that is located at the amino terminus of the putative second cytoplasmic domain, where the arginine residue is invariant. Using the m1 subtype of muscarinic acetylcholine receptors as an example, we induced a point mutation of the arginine residue at position 123 into asparagine. This mutation resulted in a precipitous decrease in the coupling of m1 receptors to activation of phosphoinositide hydrolysis, in spite of the expression of the wild-type and mutant receptors at similar concentrations in Chinese hamster ovary cells. There were no significant effects on antagonist or partial agonist binding. In marked contrast, whereas binding of the full agonist carbachol to wild-type receptors exhibited high and low affinity components, this agonist bound to a single low affinity state in asparagine-123 mutant cells. Furthermore, agonist-induced enhancement of the specific binding of guanosine-5'-O-(3-[35S] thio)triphosphate was not observed in membranes of cells expressing the mutant receptor. A similar mutation in the m2 muscarinic receptor resulted in a significant but smaller decrease in its coupling to inhibition of cAMP formation. On the other hand, a point mutation of tyrosine-124 in the m1 receptor sequence produced less marked changes in agonist-induced phosphoinositide hydrolysis and no effects on agonist or antagonist binding to the receptor. Taken together, our data demonstrate for the first time that this highly conserved arginine residue plays an important role in coupling of muscarinic receptors to signal transduction mechanisms.

Volume 45, Issue 3, pp. 517-523, 03/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				R. Case, E. Sharp, T. Benned-Jensen, M. M. Rosenkilde, N. Davis-Poynter, and H. E. Farrell Functional Analysis of the Murine Cytomegalovirus Chemokine Receptor Homologue M33: Ablation of Constitutive Signaling Is Associated with an Attenuated Phenotype In Vivo J. Virol., February 15, 2008; 82(4): 1884 - 1898. [Abstract] [Full Text] [PDF]

				H. Tokunaga, B. Matsuura, M. Dong, L. J. Miller, T. Ueda, S. Furukawa, Y. Hiasa, and M. Onji Mutational analysis of predicted intracellular loop domains of human motilin receptor Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G460 - G466. [Abstract] [Full Text] [PDF]

				K. A. Beaumont, S. L. Shekar, R. A. Newton, M. R. James, J. L. Stow, D. L. Duffy, and R. A. Sturm Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles Hum. Mol. Genet., September 15, 2007; 16(18): 2249 - 2260. [Abstract] [Full Text] [PDF]

				G. E. Rovati, V. Capra, and R. R. Neubig The Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: Beyond the Ground State Mol. Pharmacol., April 1, 2007; 71(4): 959 - 964. [Abstract] [Full Text] [PDF]

				L. Wang, C. G. Radu, L. V. Yang, L. A. Bentolila, M. Riedinger, and O. N. Witte Lysophosphatidylcholine-induced Surface Redistribution Regulates Signaling of the Murine G Protein-coupled Receptor G2A Mol. Biol. Cell, May 1, 2005; 16(5): 2234 - 2247. [Abstract] [Full Text] [PDF]

				V. Capra, A. Veltri, C. Foglia, L. Crimaldi, A. Habib, M. Parenti, and G. E. Rovati Mutational Analysis of the Highly Conserved ERY Motif of the Thromboxane A2 Receptor: Alternative Role in G Protein-Coupled Receptor Signaling Mol. Pharmacol., October 1, 2004; 66(4): 880 - 889. [Abstract] [Full Text] [PDF]

				Z. Gaborik, G. Jagadeesh, M. Zhang, A. Spat, K. J. Catt, and L. Hunyady The Role of a Conserved Region of the Second Intracellular Loop in AT1 Angiotensin Receptor Activation and Signaling Endocrinology, June 1, 2003; 144(6): 2220 - 2228. [Abstract] [Full Text] [PDF]

				T. R. Ott, B. E. Troskie, R. W. Roeske, N. Illing, C. A. Flanagan, and R. P. Millar Two Mutations in Extracellular Loop 2 of the Human GnRH Receptor Convert an Antagonist to an Agonist Mol. Endocrinol., May 1, 2002; 16(5): 1079 - 1088. [Abstract] [Full Text] [PDF]

				T. Kroslak, T. Koch, E. Kahl, and V. Hollt Human Phosphatidylethanolamine-binding Protein Facilitates Heterotrimeric G Protein-dependent Signaling J. Biol. Chem., October 19, 2001; 276(43): 39772 - 39778. [Abstract] [Full Text] [PDF]

				S. Kitanovic, T. Yuen, C. A. Flanagan, B. J. Ebersole, and S. C. Sealfon Insertional Mutagenesis of the Arginine Cage Domain of the Gonadotropin-Releasing Hormone Receptor Mol. Endocrinol., March 1, 2001; 15(3): 390 - 397. [Abstract] [Full Text]

				A. E. Alewijnse, H. Timmerman, E. H. Jacobs, M. J. Smit, E. Roovers, S. Cotecchia, and R. Leurs The Effect of Mutations in the DRY Motif on the Constitutive Activity and Structural Instability of the Histamine H2 Receptor Mol. Pharmacol., May 1, 2000; 57(5): 890 - 898. [Abstract] [Full Text]

				A. Scheer, T. Costa, F. Fanelli, P. G. De Benedetti, S. Mhaouty-Kodja, L. Abuin, M. Nenniger-Tosato, and S. Cotecchia Mutational Analysis of the Highly Conserved Arginine within the Glu/Asp-Arg-Tyr Motif of the alpha 1b-Adrenergic Receptor: Effects on Receptor Isomerization and Activation Mol. Pharmacol., February 1, 2000; 57(2): 219 - 231. [Abstract] [Full Text]

				L. L. K. Elias, A. Huebner, G. D. Pullinger, A. Mirtella, and A. J. L. Clark Functional Characterization of Naturally Occurring Mutations of the Human Adrenocorticotropin Receptor: Poor Correlation of Phenotype and Genotype J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2766 - 2770. [Abstract] [Full Text]

				F. Fanelli, P. Barbier, D. Zanchetta, P. G. de Benedetti, and B. Chini Activation Mechanism of Human Oxytocin Receptor: A Combined Study of Experimental and Computer-Simulated Mutagenesis Mol. Pharmacol., July 1, 1999; 56(1): 214 - 225. [Abstract] [Full Text]

				Z.-L. Lu and E. C. Hulme The Functional Topography of Transmembrane Domain 3 of the M1 Muscarinic Acetylcholine Receptor, Revealed by Scanning Mutagenesis J. Biol. Chem., March 12, 1999; 274(11): 7309 - 7315. [Abstract] [Full Text] [PDF]

				S. Y. Hsu, S.-G. Liang, and A. J. W. Hsueh Characterization of Two LGR Genes Homologous to Gonadotropin and Thyrotropin Receptors with Extracellular Leucine-Rich Repeats and a G Protein-Coupled, Seven-Transmembrane Region Mol. Endocrinol., December 1, 1998; 12(12): 1830 - 1845. [Abstract] [Full Text]

				M. P. Caulfield and N. J. M. Birdsall International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors Pharmacol. Rev., June 1, 1998; 50(2): 279 - 290. [Abstract] [Full Text] [PDF]

				A. Christopoulos, T. L. Pierce, J. L. Sorman, and E. E. El-Fakahany On the Unique Binding and Activating Properties of Xanomeline at the M1 Muscarinic Acetylcholine Receptor Mol. Pharmacol., June 1, 1998; 53(6): 1120 - 1130. [Abstract] [Full Text]

				K. K. Arora, Z. Cheng, and K. J. Catt Mutations of the Conserved DRS Motif in the Second Intracellular Loop of the Gonadotropin-Releasing Hormone Receptor Affect Expression, Activation, and Internalization Mol. Endocrinol., August 1, 1997; 11(9): 1203 - 1212. [Abstract] [Full Text]

				M. Farzan, H. Choe, K. A. Martin, Y. Sun, M. Sidelko, C. R. Mackay, N. P. Gerard, J. Sodroski, and C. Gerard HIV-1 Entry and Macrophage Inflammatory Protein-1beta -mediated Signaling Are Independent Functions of the Chemokine Receptor CCR5 J. Biol. Chem., March 14, 1997; 272(11): 6854 - 6857. [Abstract] [Full Text] [PDF]

				Z.-L. Lu, C. A. Curtis, P. G. Jones, J. Pavia, and E. C. Hulme The Role of the Aspartate-Arginine-Tyrosine Triad in the m1 Muscarinic Receptor: Mutations of Aspartate 122 and Tyrosine 124 Decrease Receptor Expression but Do Not Abolish Signaling Mol. Pharmacol., February 1, 1997; 51(2): 234 - 241. [Abstract] [Full Text] [PDF]

				S. Acharya and S. S. Karnik Modulation of GDP Release from Transducin by the Conserved Glu134-Arg135 Sequence in Rhodopsin J. Biol. Chem., October 11, 1996; 271(41): 25406 - 25411. [Abstract] [Full Text] [PDF]

				N. Blin, J. Yun, and J. Wess Mapping of Single Amino Acid Residues Required for Selective Activation of G[IMAGE] by the m3 Muscarinic Acetylcholine Receptor J. Biol. Chem., July 28, 1995; 270(30): 17741 - 17748. [Abstract] [Full Text] [PDF]